ID AGRB2_HUMAN Reviewed; 1585 AA. AC O60241; B9EGK9; Q5T6K0; Q8NGW8; Q96GZ9; DT 01-DEC-2000, integrated into UniProtKB/Swiss-Prot. DT 05-MAY-2009, sequence version 2. DT 13-FEB-2019, entry version 177. DE RecName: Full=Adhesion G protein-coupled receptor B2 {ECO:0000303|PubMed:25713288}; DE AltName: Full=Brain-specific angiogenesis inhibitor 2; DE Flags: Precursor; GN Name=ADGRB2 {ECO:0000312|HGNC:HGNC:944}; Synonyms=BAI2; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2). RC TISSUE=Fetal brain; RX PubMed=9533023; RA Shiratsuchi T., Nishimori H., Ichise H., Nakamura Y., Tokino T.; RT "Cloning and characterization of BAI2 and BAI3, novel genes homologous RT to brain-specific angiogenesis inhibitor 1 (BAI1)."; RL Cytogenet. Cell Genet. 79:103-108(1997). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RA Suwa M., Sato T., Okouchi I., Arita M., Futami K., Matsumoto S., RA Tsutsumi S., Aburatani H., Asai K., Akiyama Y.; RT "Genome-wide discovery and analysis of human seven transmembrane helix RT receptor genes."; RL Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16710414; DOI=10.1038/nature04727; RA Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., RA Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., RA Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F., RA McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C., RA Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P., RA Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K., RA Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G., RA Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D., RA Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G., RA Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J., RA Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H., RA Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L., RA Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J., RA Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., RA Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D., RA Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G., RA Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M., RA Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J., RA Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M., RA Loveland J., Lovell J., Lush M.J., Lyne R., Martin S., RA Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S., RA Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N., RA Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V., RA Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J., RA Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E., RA Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., RA Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z., RA Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E., RA Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A., RA Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R., RA Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V., RA Beck S., Rogers J., Bentley D.R.; RT "The DNA sequence and biological annotation of human chromosome 1."; RL Nature 441:315-321(2006). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND NUCLEOTIDE RP SEQUENCE [LARGE SCALE MRNA] OF 1293-1585 (ISOFORM 1). RC TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA RT project: the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP CLEAVAGE BY FURIN, PROTEOLYTIC PROCESSING, MUTAGENESIS OF TRP-889; RP CYS-908 AND SER-912, SUBUNIT, PROTEIN SEQUENCE OF 296-306, RP GLYCOSYLATION, FUNCTION, AND ACTIVITY REGULATION. RX PubMed=20367554; DOI=10.3109/10799891003671139; RA Okajima D., Kudo G., Yokota H.; RT "Brain-specific angiogenesis inhibitor 2 (BAI2) may be activated by RT proteolytic processing."; RL J. Recept. Signal Transduct. 30:143-153(2010). RN [6] RP INTERACTION WITH TAX1BP3. RX PubMed=21787750; DOI=10.1016/j.bbrc.2011.07.029; RA Zencir S., Ovee M., Dobson M.J., Banerjee M., Topcu Z., Mohanty S.; RT "Identification of brain-specific angiogenesis inhibitor 2 as an RT interaction partner of glutaminase interacting protein."; RL Biochem. Biophys. Res. Commun. 411:792-797(2011). RN [7] RP NOMENCLATURE. RX PubMed=25713288; DOI=10.1124/pr.114.009647; RA Hamann J., Aust G., Arac D., Engel F.B., Formstone C., Fredriksson R., RA Hall R.A., Harty B.L., Kirchhoff C., Knapp B., Krishnan A., RA Liebscher I., Lin H.H., Martinelli D.C., Monk K.R., Peeters M.C., RA Piao X., Promel S., Schoneberg T., Schwartz T.W., Singer K., RA Stacey M., Ushkaryov Y.A., Vallon M., Wolfrum U., Wright M.W., Xu L., RA Langenhan T., Schioth H.B.; RT "International union of basic and clinical pharmacology. XCIV. RT Adhesion G protein-coupled receptors."; RL Pharmacol. Rev. 67:338-367(2015). RN [8] RP SUBCELLULAR LOCATION, VARIANT TRP-1465, CHARACTERIZATION OF VARIANT RP TRP-1465, INTERACTION WITH SH3GL2 AND GNAZ, AND FUNCTION. RX PubMed=28891236; DOI=10.1002/humu.23336; RA Purcell R.H., Toro C., Gahl W.A., Hall R.A.; RT "A disease-associated mutation in the adhesion GPCR BAI2 (ADGRB2) RT increases receptor signaling activity."; RL Hum. Mutat. 38:1751-1760(2017). CC -!- FUNCTION: Orphan G-protein coupled receptor involved in cell CC adhesion and probably in cell-cell interactions. Activates NFAT- CC signaling pathway, a transcription factor, via the G-protein GNAZ CC (PubMed:20367554, PubMed:28891236). Involved in angiogenesis CC inhibition (By similarity). {ECO:0000250|UniProtKB:Q8CGM1, CC ECO:0000269|PubMed:20367554, ECO:0000269|PubMed:28891236}. CC -!- ACTIVITY REGULATION: Receptor activity is regulated by proteolytic CC processing. The long N-terminal has a an inhibitory effect on the CC constitutive signaling activity. Removal of the N-terminal region CC induces an increase of the receptor activity. CC {ECO:0000269|PubMed:20367554, ECO:0000269|PubMed:28891236}. CC -!- SUBUNIT: Heterodimer of 2 chains generated by proteolytic CC processing; the large extracellular N-terminal fragment and the CC membrane-bound C-terminal fragment predominantly remain associated CC and non-covalently linked. Interacts with GABPB2 (By similarity). CC Interacts (via carboxy-terminus) with TAX1BP3 (PubMed:21787750). CC Interacts with GNAZ (PubMed:28891236). Interacts with SH3GL2 CC (PubMed:28891236). {ECO:0000250|UniProtKB:Q8CGM1, CC ECO:0000269|PubMed:21787750, ECO:0000269|PubMed:28891236}. CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:28891236}; CC Multi-pass membrane protein {ECO:0000255}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=4; CC Name=1; CC IsoId=O60241-1; Sequence=Displayed; CC Name=2; CC IsoId=O60241-2; Sequence=VSP_037047; CC Name=3; CC IsoId=O60241-3; Sequence=VSP_037045; CC Name=4; CC IsoId=O60241-4; Sequence=VSP_037046, VSP_037047; CC -!- TISSUE SPECIFICITY: Strongly expressed in brain. Also detected in CC heart, thymus, skeletal muscle, and different cell lines. CC -!- PTM: Autoproteolytic processes at the GPS domain; this cleavage CC modulates receptor activity. Additionally, furin is involved in CC the cleavage at another site, in the middle of the extracellular CC domain, generating a soluble fragment. CC {ECO:0000269|PubMed:20367554}. CC -!- PTM: Glycosylated. {ECO:0000269|PubMed:20367554}. CC -!- SIMILARITY: Belongs to the G-protein coupled receptor 2 family. CC Adhesion G-protein coupled receptor (ADGR) subfamily. CC {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=BAA25362.1; Type=Erroneous initiation; Evidence={ECO:0000305}; CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC ----------------------------------------------------------------------- DR EMBL; AB005298; BAA25362.1; ALT_INIT; mRNA. DR EMBL; AB065648; BAC05874.1; -; Genomic_DNA. DR EMBL; AC114488; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AL354919; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC009035; AAH09035.1; -; mRNA. DR EMBL; BC136533; AAI36534.1; -; mRNA. DR CCDS; CCDS72746.1; -. [O60241-4] DR CCDS; CCDS72747.1; -. [O60241-2] DR PIR; T00027; T00027. DR RefSeq; NP_001281264.1; NM_001294335.1. [O60241-2] DR RefSeq; NP_001281265.1; NM_001294336.1. [O60241-4] DR RefSeq; XP_011540150.1; XM_011541848.2. [O60241-1] DR RefSeq; XP_011540151.1; XM_011541849.2. [O60241-3] DR RefSeq; XP_016857388.1; XM_017001899.1. [O60241-1] DR RefSeq; XP_016857389.1; XM_017001900.1. [O60241-2] DR RefSeq; XP_016857394.1; XM_017001905.1. [O60241-4] DR UniGene; Hs.524138; -. DR ProteinModelPortal; O60241; -. DR SMR; O60241; -. DR BioGrid; 107052; 3. DR IntAct; O60241; 4. DR MINT; O60241; -. DR STRING; 9606.ENSP00000362762; -. DR MEROPS; P02.029; -. DR TCDB; 9.A.14.6.6; the g-protein-coupled receptor (gpcr) family. DR CarbonylDB; O60241; -. DR iPTMnet; O60241; -. DR PhosphoSitePlus; O60241; -. DR BioMuta; ADGRB2; -. DR EPD; O60241; -. DR jPOST; O60241; -. DR PaxDb; O60241; -. DR PeptideAtlas; O60241; -. DR PRIDE; O60241; -. DR ProteomicsDB; 49271; -. DR ProteomicsDB; 49272; -. [O60241-2] DR ProteomicsDB; 49273; -. [O60241-3] DR ProteomicsDB; 49274; -. [O60241-4] DR Ensembl; ENST00000373655; ENSP00000362759; ENSG00000121753. [O60241-2] DR Ensembl; ENST00000373658; ENSP00000362762; ENSG00000121753. [O60241-1] DR Ensembl; ENST00000527361; ENSP00000435397; ENSG00000121753. [O60241-4] DR GeneID; 576; -. DR KEGG; hsa:576; -. DR UCSC; uc001btn.4; human. [O60241-1] DR CTD; 576; -. DR DisGeNET; 576; -. DR EuPathDB; HostDB:ENSG00000121753.12; -. DR GeneCards; ADGRB2; -. DR H-InvDB; HIX0023509; -. DR HGNC; HGNC:944; ADGRB2. DR HPA; HPA052612; -. DR HPA; HPA054617; -. DR MIM; 602683; gene. DR neXtProt; NX_O60241; -. DR OpenTargets; ENSG00000121753; -. DR PharmGKB; PA25248; -. DR eggNOG; ENOG410IEA0; Eukaryota. DR eggNOG; ENOG4111FBM; LUCA. DR GeneTree; ENSGT00940000160103; -. DR HOGENOM; HOG000230916; -. DR HOVERGEN; HBG004813; -. DR InParanoid; O60241; -. DR KO; K04597; -. DR OMA; CNNTATC; -. DR OrthoDB; 27621at2759; -. DR PhylomeDB; O60241; -. DR TreeFam; TF331634; -. DR ChiTaRS; ADGRB2; human. DR GeneWiki; Brain-specific_angiogenesis_inhibitor_2; -. DR GenomeRNAi; 576; -. DR PRO; PR:O60241; -. DR Proteomes; UP000005640; Chromosome 1. DR Bgee; ENSG00000121753; Expressed in 145 organ(s), highest expression level in right frontal lobe. DR ExpressionAtlas; O60241; baseline and differential. DR Genevisible; O60241; HS. DR GO; GO:0005813; C:centrosome; IDA:HPA. DR GO; GO:0016021; C:integral component of membrane; TAS:GDB. DR GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central. DR GO; GO:0005886; C:plasma membrane; IDA:UniProtKB. DR GO; GO:0004930; F:G protein-coupled receptor activity; IMP:UniProtKB. DR GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; IBA:GO_Central. DR GO; GO:0033173; P:calcineurin-NFAT signaling cascade; IMP:UniProtKB. DR GO; GO:0007166; P:cell surface receptor signaling pathway; IEA:InterPro. DR GO; GO:0007186; P:G protein-coupled receptor signaling pathway; IDA:UniProtKB. DR GO; GO:0016525; P:negative regulation of angiogenesis; IEA:InterPro. DR GO; GO:0007422; P:peripheral nervous system development; IBA:GO_Central. DR GO; GO:0051965; P:positive regulation of synapse assembly; IEA:Ensembl. DR Gene3D; 2.20.100.10; -; 4. DR Gene3D; 4.10.1240.10; -; 1. DR InterPro; IPR032471; GAIN_dom_N. DR InterPro; IPR017981; GPCR_2-like. DR InterPro; IPR008077; GPCR_2_brain_angio_inhib. DR InterPro; IPR036445; GPCR_2_extracell_dom_sf. DR InterPro; IPR001879; GPCR_2_extracellular_dom. DR InterPro; IPR000832; GPCR_2_secretin-like. DR InterPro; IPR000203; GPS. DR InterPro; IPR000884; TSP1_rpt. DR InterPro; IPR036383; TSP1_rpt_sf. DR Pfam; PF00002; 7tm_2; 1. DR Pfam; PF16489; GAIN; 1. DR Pfam; PF01825; GPS; 1. DR Pfam; PF00090; TSP_1; 4. DR PRINTS; PR01694; BAIPRECURSOR. DR PRINTS; PR00249; GPCRSECRETIN. DR SMART; SM00303; GPS; 1. DR SMART; SM00008; HormR; 1. DR SMART; SM00209; TSP1; 4. DR SUPFAM; SSF82895; SSF82895; 4. DR PROSITE; PS50227; G_PROTEIN_RECEP_F2_3; 1. DR PROSITE; PS50261; G_PROTEIN_RECEP_F2_4; 1. DR PROSITE; PS50221; GPS; 1. DR PROSITE; PS50092; TSP1; 4. PE 1: Evidence at protein level; KW Alternative splicing; Cell membrane; Complete proteome; KW Direct protein sequencing; Disease mutation; Disulfide bond; KW G-protein coupled receptor; Glycoprotein; Membrane; Phosphoprotein; KW Polymorphism; Receptor; Reference proteome; Repeat; Signal; KW Transducer; Transmembrane; Transmembrane helix. FT SIGNAL 1 32 {ECO:0000255}. FT CHAIN 33 1585 Adhesion G protein-coupled receptor B2. FT /FTId=PRO_0000012864. FT TOPO_DOM 33 936 Extracellular. {ECO:0000305}. FT TRANSMEM 937 957 Helical; Name=1. {ECO:0000255}. FT TOPO_DOM 958 965 Cytoplasmic. {ECO:0000305}. FT TRANSMEM 966 986 Helical; Name=2. {ECO:0000255}. FT TOPO_DOM 987 994 Extracellular. {ECO:0000305}. FT TRANSMEM 995 1015 Helical; Name=3. {ECO:0000255}. FT TOPO_DOM 1016 1036 Cytoplasmic. {ECO:0000305}. FT TRANSMEM 1037 1057 Helical; Name=4. {ECO:0000255}. FT TOPO_DOM 1058 1078 Extracellular. {ECO:0000305}. FT TRANSMEM 1079 1099 Helical; Name=5. {ECO:0000255}. FT TOPO_DOM 1100 1121 Cytoplasmic. {ECO:0000305}. FT TRANSMEM 1122 1142 Helical; Name=6. {ECO:0000255}. FT TOPO_DOM 1143 1153 Extracellular. {ECO:0000305}. FT TRANSMEM 1154 1174 Helical; Name=7. {ECO:0000255}. FT TOPO_DOM 1175 1585 Cytoplasmic. {ECO:0000305}. FT DOMAIN 309 362 TSP type-1 1. {ECO:0000255|PROSITE- FT ProRule:PRU00210}. FT DOMAIN 364 417 TSP type-1 2. {ECO:0000255|PROSITE- FT ProRule:PRU00210}. FT DOMAIN 419 472 TSP type-1 3. {ECO:0000255|PROSITE- FT ProRule:PRU00210}. FT DOMAIN 475 528 TSP type-1 4. {ECO:0000255|PROSITE- FT ProRule:PRU00210}. FT DOMAIN 871 923 GPS. {ECO:0000255|PROSITE- FT ProRule:PRU00098}. FT COMPBIAS 129 134 Poly-Glu. FT COMPBIAS 189 192 Poly-Asn. FT COMPBIAS 234 237 Poly-Thr. FT COMPBIAS 1315 1318 Poly-Pro. FT COMPBIAS 1364 1370 Poly-Gly. FT COMPBIAS 1425 1430 Poly-Pro. FT SITE 296 297 Cleavage; by furin. FT {ECO:0000269|PubMed:20367554}. FT MOD_RES 1351 1351 Phosphotyrosine. FT {ECO:0000250|UniProtKB:Q8CGM1}. FT CARBOHYD 106 106 N-linked (GlcNAc...) asparagine. FT {ECO:0000255}. FT CARBOHYD 191 191 N-linked (GlcNAc...) asparagine. FT {ECO:0000255}. FT CARBOHYD 192 192 N-linked (GlcNAc...) asparagine. FT {ECO:0000255}. FT CARBOHYD 356 356 N-linked (GlcNAc...) asparagine. FT {ECO:0000255}. FT CARBOHYD 437 437 N-linked (GlcNAc...) asparagine. FT {ECO:0000255}. FT CARBOHYD 560 560 N-linked (GlcNAc...) asparagine. FT {ECO:0000255}. FT CARBOHYD 645 645 N-linked (GlcNAc...) asparagine. FT {ECO:0000255}. FT CARBOHYD 867 867 N-linked (GlcNAc...) asparagine. FT {ECO:0000255}. FT DISULFID 321 355 {ECO:0000255|PROSITE-ProRule:PRU00210}. FT DISULFID 325 361 {ECO:0000255|PROSITE-ProRule:PRU00210}. FT DISULFID 336 345 {ECO:0000255|PROSITE-ProRule:PRU00210}. FT DISULFID 376 411 {ECO:0000255|PROSITE-ProRule:PRU00210}. FT DISULFID 380 416 {ECO:0000255|PROSITE-ProRule:PRU00210}. FT DISULFID 391 401 {ECO:0000255|PROSITE-ProRule:PRU00210}. FT DISULFID 431 466 {ECO:0000255|PROSITE-ProRule:PRU00210}. FT DISULFID 435 471 {ECO:0000255|PROSITE-ProRule:PRU00210}. FT DISULFID 446 456 {ECO:0000255|PROSITE-ProRule:PRU00210}. FT DISULFID 487 522 {ECO:0000255|PROSITE-ProRule:PRU00210}. FT DISULFID 491 527 {ECO:0000255|PROSITE-ProRule:PRU00210}. FT DISULFID 502 512 {ECO:0000255|PROSITE-ProRule:PRU00210}. FT DISULFID 534 569 {ECO:0000255|PROSITE-ProRule:PRU00210}. FT DISULFID 557 587 {ECO:0000255|PROSITE-ProRule:PRU00210}. FT DISULFID 874 906 {ECO:0000255|PROSITE-ProRule:PRU00210}. FT DISULFID 894 908 {ECO:0000255|PROSITE-ProRule:PRU00210}. FT VAR_SEQ 1 12 Missing (in isoform 3). {ECO:0000305}. FT /FTId=VSP_037045. FT VAR_SEQ 1119 1151 Missing (in isoform 4). FT {ECO:0000303|PubMed:15489334}. FT /FTId=VSP_037046. FT VAR_SEQ 1473 1473 Missing (in isoform 2 and isoform 4). FT {ECO:0000303|PubMed:15489334, FT ECO:0000303|PubMed:9533023}. FT /FTId=VSP_037047. FT VARIANT 1465 1465 R -> W (probable disease-associated FT mutation found in a patient with FT progressive spastic paraparesis and other FT neurological symptoms; enhances receptor FT surface expression; increases the FT constitutive signaling activity; does not FT affect interaction with GNAZ; promotes FT enhanced interaction with GNAI1; FT decreases interaction with SH3GL2; FT dbSNP:rs778361520). FT {ECO:0000269|PubMed:28891236}. FT /FTId=VAR_079840. FT MUTAGEN 889 889 W->S: Inhibits autoproteolytic cleavage. FT {ECO:0000269|PubMed:20367554}. FT MUTAGEN 908 908 C->W: Inhibits autoproteolytic cleavage. FT {ECO:0000269|PubMed:20367554}. FT MUTAGEN 912 912 S->P: Inhibits autoproteolytic cleavage. FT {ECO:0000269|PubMed:20367554}. FT CONFLICT 325 325 C -> R (in Ref. 4; AAI36534). FT {ECO:0000305}. SQ SEQUENCE 1585 AA; 172656 MW; 56D253AE0AB1552D CRC64; MENTGWMGKG HRMTPACPLL LSVILSLRLA TAFDPAPSAC SALASGVLYG AFSLQDLFPT IASGCSWTLE NPDPTKYSLY LRFNRQEQVC AHFAPRLLPL DHYLVNFTCL RPSPEEAVAQ AESEVGRPEE EEAEAAAGLE LCSGSGPFTF LHFDKNFVQL CLSAEPSEAP RLLAPAALAF RFVEVLLINN NNSSQFTCGV LCRWSEECGR AAGRACGFAQ PGCSCPGEAG AGSTTTTSPG PPAAHTLSNA LVPGGPAPPA EADLHSGSSN DLFTTEMRYG EEPEEEPKVK TQWPRSADEP GLYMAQTGDP AAEEWSPWSV CSLTCGQGLQ VRTRSCVSSP YGTLCSGPLR ETRPCNNSAT CPVHGVWEEW GSWSLCSRSC GRGSRSRMRT CVPPQHGGKA CEGPELQTKL CSMAACPVEG QWLEWGPWGP CSTSCANGTQ QRSRKCSVAG PAWATCTGAL TDTRECSNLE CPATDSKWGP WNAWSLCSKT CDTGWQRRFR MCQATGTQGY PCEGTGEEVK PCSEKRCPAF HEMCRDEYVM LMTWKKAAAG EIIYNKCPPN ASGSASRRCL LSAQGVAYWG LPSFARCISH EYRYLYLSLR EHLAKGQRML AGEGMSQVVR SLQELLARRT YYSGDLLFSV DILRNVTDTF KRATYVPSAD DVQRFFQVVS FMVDAENKEK WDDAQQVSPG SVHLLRVVED FIHLVGDALK AFQSSLIVTD NLVISIQREP VSAVSSDITF PMRGRRGMKD WVRHSEDRLF LPKEVLSLSS PGKPATSGAA GSPGRGRGPG TVPPGPGHSH QRLLPADPDE SSYFVIGAVL YRTLGLILPP PRPPLAVTSR VMTVTVRPPT QPPAEPLITV ELSYIINGTT DPHCASWDYS RADASSGDWD TENCQTLETQ AAHTRCQCQH LSTFAVLAQP PKDLTLELAG SPSVPLVIGC AVSCMALLTL LAIYAAFWRF IKSERSIILL NFCLSILASN ILILVGQSRV LSKGVCTMTA AFLHFFFLSS FCWVLTEAWQ SYLAVIGRMR TRLVRKRFLC LGWGLPALVV AVSVGFTRTK GYGTSSYCWL SLEGGLLYAF VGPAAVIVLV NMLIGIIVFN KLMARDGISD KSKKQRAGSE RCPWASLLLP CSACGAVPSP LLSSASARNA MASLWSSCVV LPLLALTWMS AVLAMTDRRS VLFQALFAVF NSAQGFVITA VHCFLRREVQ DVVKCQMGVC RADESEDSPD SCKNGQLQIL SDFEKDVDLA CQTVLFKEVN TCNPSTITGT LSRLSLDEDE EPKSCLVGPE GSLSFSPLPG NILVPMAASP GLGEPPPPQE ANPVYMCGEG GLRQLDLTWL RPTEPGSEGD YMVLPRRTLS LQPGGGGGGG EDAPRARPEG TPRRAAKTVA HTEGYPSFLS VDHSGLGLGP AYGSLQNPYG MTFQPPPPTP SARQVPEPGE RSRTMPRTVP GSTMKMGSLE RKKLRYSDLD FEKVMHTRKR HSELYHELNQ KFHTFDRYRS QSTAKREKRW SVSSGGAAER SVCTDKPSPG ERPSLSQHRR HQSWSTFKSM TLGSLPPKPR ERLTLHRAAA WEPTEPPDGD FQTEV //